Last reviewed · How we verify
NCT03652714
The Effect of Ganglion Sphenopalatine Block (GSP-block) Versus Placebo on Postdural Puncture Headache
Phase 3 trial testing Ganglion sphenopalatine block with local anesthetic in Postdural Puncture Headache in 40 participants. Completed in 9 September 2019.
2 September 2019
Quick facts
| Lead sponsor | University Hospital Bispebjerg and Frederiksberg |
|---|---|
| Phase | Phase 3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 19 September 2018 |
| Primary completion | 2 September 2019 |
| Estimated completion | 9 September 2019 |
| Sites | 5 locations across Denmark |
Drugs / interventions tested
- Ganglion sphenopalatine block with local anesthetic
- Ganglion sphenopalatine block with placebo
Conditions studied
- Postdural Puncture Headache — all drugs for Postdural Puncture Headache →
- Sphenopalatine Ganglion Block — all drugs for Sphenopalatine Ganglion Block →
Sponsor
University Hospital Bispebjerg and Frederiksberg
Who can join
18 and older, any sex, with Postdural Puncture Headache or Sphenopalatine Ganglion Block. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate the effect of the ganglion sphenopalatine block (GSP block) on postdural puncture headache.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Sphenopalatine ganglion block for the treatment of postdural puncture headache: a randomised, blinded, clinical trial.
Jespersen MS, Jaeger P, Ægidius KL, Fabritius ML, et al · · 2020 · cited 40× · PMID 32303377 · DOI 10.1016/j.bja.2020.02.025
Verify or expand the search:
- PubMed search for NCT03652714
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Postdural Puncture Headache
Currently open trials in the same condition.
- NCT07075874 — Neutrophil to Lymphocyte Ratio and Postdural Headache · recruiting
Other University Hospital Bispebjerg and Frederiksberg trials
Trials by the same sponsor.
- NCT07060586 — The Effect of Sphenopalatine Ganglion Block on Headache and Vasalgia · NA · completed
- NCT06911411 — PALLIATIVE ASSESSMENT COHORT IN THE GERIATRIC EMERGENCY SETTING · not yet recruiting
- NCT06405750 — Left Atrial Appendage Arrhythmogenic and Thrombogenic Substrate · NA · recruiting
- NCT06532825 — Cardiac Autonomic Dysfunction As a Sign of Irreversible Advanced Heart Failure · recruiting
- NCT06184581 — Lithium Versus Lamotrigine in Bipolar Disorder, Type II · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03652714 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital Bispebjerg and Frederiksberg
- Last refreshed: 11 September 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03652714.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing